Rockefeller Financial Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$16.7M Buy
196,845
+24,648
+14% +$2.04M 0.26% 88
2017
Q3
$13.3M Sell
172,197
-7,518
-4% -$575K 0.25% 90
2017
Q2
$14M Buy
179,715
+3,308
+2% +$237K 0.28% 81
2017
Q1
$12.7M Hold
176,407
0.25% 87
2016
Q4
$10.9M Buy
176,407
+85
+0% +$5.21K 0.22% 95
2016
Q3
$11.4M Hold
176,322
0.24% 90
2016
Q2
$11.1M Sell
176,322
-2,030
-1% -$120K 0.22% 88
2016
Q1
$10.3M Sell
178,352
-9,071
-5% -$513K 0.2% 89
2015
Q4
$10.1M Sell
187,423
-2,333
-1% -$132K 0.2% 100
2015
Q3
$9.67M Buy
189,756
+1,430
+0.8% +$77K 0.2% 100
2015
Q2
$10.6M Sell
188,326
-912
-0.5% -$57.6K 0.22% 94
2015
Q1
$13.6M Buy
189,238
+2,779
+1% +$181K 0.29% 75
2014
Q4
$10.5M Buy
186,459
+5,252
+3% +$274K 0.23% 85
2014
Q3
$8.93M Buy
181,207
+4,467
+3% +$228K 0.2% 92
2014
Q2
$8.95M Sell
176,740
-3,094
-2% -$153K 0.2% 95
2014
Q1
$8.04M Sell
179,834
-70
-0% -$3.14K 0.17% 114
2013
Q4
$8.47M Buy
179,904
+93
+0.1% +$4.71K 0.18% 118
2013
Q3
$9.5M Buy
179,811
+20
+0% +$970 0.22% 102
2013
Q2
$8.11M Buy
+179,791
New +$8.53M 0.19% 108

Other funds holding RMD

Rockefeller Financial Services's RMD Position: Q4 2017 in Review

Rockefeller Financial Services increased its ResMed (RMD) stake by 14% in Q4 2017, buying an estimated $2.04M and bringing the position to 196,845 shares worth $16.7M. The position accounts for 0.26% of the portfolio, ranked #88.

Rockefeller Financial Services first reported a position in RMD in Q2 2013 and has held it in 19 quarters since. 415 funds tracked by Wall St. Rank hold RMD as of Q4 2017.

  • Rockefeller Financial Services held 196,845 shares of ResMed worth $16.7M as of Q4 2017.
  • Rockefeller Financial Services bought 24,648 ResMed shares in Q4 2017, an estimated $2.04M.
  • ResMed made up 0.26% of Rockefeller Financial Services's portfolio in Q4 2017, its #88 holding.
  • Rockefeller Financial Services first reported a position in ResMed in Q2 2013 and has held it in 19 quarters since.
  • 415 funds tracked by Wall St. Rank held ResMed as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.